MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Relay Therapeutics Inc

Fechado

SetorSaúde

6.11 4.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.81

Máximo

6.15

Indicadores-chave

By Trading Economics

Rendimento

6.7M

-70M

Vendas

-7M

677K

Margem de lucro

-10,395.126

Funcionários

197

EBITDA

8M

-77M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+145.26% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

338M

964M

Abertura anterior

1.84

Fecho anterior

6.11

Sentimento de Notícias

By Acuity

50%

50%

183 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Relay Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de out. de 2025, 20:45 UTC

Ganhos

Costco Wholesale Sales Climb in September, Early October

8 de out. de 2025, 20:12 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 de out. de 2025, 16:39 UTC

Grandes Movimentos do Mercado

Mining Shares Rise as Gold Prices Soar

8 de out. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 de out. de 2025, 23:43 UTC

Conversa de Mercado

Gold Falls on Possible Profit-Taking -- Market Talk

8 de out. de 2025, 23:18 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics to Finance Acquisition Using Internal Funds

8 de out. de 2025, 23:17 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 de out. de 2025, 23:16 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 de out. de 2025, 21:54 UTC

Conversa de Mercado
Ganhos

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 de out. de 2025, 21:30 UTC

Conversa de Mercado

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 de out. de 2025, 21:26 UTC

Conversa de Mercado
Ganhos

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de out. de 2025, 19:15 UTC

Conversa de Mercado

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 de out. de 2025, 19:01 UTC

Conversa de Mercado

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 de out. de 2025, 18:47 UTC

Conversa de Mercado

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 de out. de 2025, 18:46 UTC

Aquisições, Fusões, Aquisições de Empresas

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 de out. de 2025, 18:46 UTC

Aquisições, Fusões, Aquisições de Empresas

TaskUs Will Remain a Publicly Traded Co >TASK

8 de out. de 2025, 18:46 UTC

Aquisições, Fusões, Aquisições de Empresas

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 de out. de 2025, 18:45 UTC

Aquisições, Fusões, Aquisições de Empresas

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 de out. de 2025, 18:07 UTC

Conversa de Mercado

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 de out. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Energy & Utilities Roundup: Market Talk

8 de out. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de out. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

8 de out. de 2025, 15:57 UTC

Conversa de Mercado

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 de out. de 2025, 15:56 UTC

Conversa de Mercado

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 de out. de 2025, 15:53 UTC

Conversa de Mercado

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 de out. de 2025, 15:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 de out. de 2025, 15:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 de out. de 2025, 15:43 UTC

Aquisições, Fusões, Aquisições de Empresas

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 de out. de 2025, 15:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Comparação entre Pares

Variação de preço

Relay Therapeutics Inc Previsão

Preço-alvo

By TipRanks

145.26% parte superior

Previsão para 12 meses

Média 13.71 USD  145.26%

Máximo 19 USD

Mínimo 4 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Relay Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

9 ratings

7

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

2.88 / 3.285Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

183 / 371 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Relay Therapeutics Inc

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and Migoprotafib (GDC-1971), an oral, small molecule, potent and selective inhibitor of the protein tyrosine phosphatase SHP2 that binds and stabilizes Src homology region 2 domain-containing phosphatase-2 (SHP2) as a monotherapy in patients with advanced or metastatic solid tumors. In addition, it has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of GDC-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat